Control of MRSA in Nursing Homes: Decolonization vs Standard Precautions

NCT ID: NCT01138462

Last Updated: 2020-03-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

157 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-06-30

Study Completion Date

2011-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the better approach between the currently procedure (i.e. standards precautions) and a reinforced strategy to control MRSA transmission in the institutionalized population of nursing homes in Canton of Vaud, Switzerland.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

MRSA carriage among nursing homes residents of Canton Vaud, Switzerland, is increasing, despite use of standard precautions. Recommendation to prevent MRSA transmission in long term care facilities are lacking. We aim to reinforce the current infection control strategy by general MRSA screening of institutionalised residents and decolonisation of MRSA carriers. Because the uncertainties in the impact of this reinforced strategy, we aim to compare this action to the policy actually applied.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Methicillin-Resistant Staphylococcus Aureus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard Precautions

control arm, standards precautions for all residents living in the nursing home of control arm, including MRSA carriers

Group Type NO_INTERVENTION

No interventions assigned to this group

Intervention

Intervention arm, standards precautions for all residents living in nursing homes of intervention arm, and topical decolonization for MRSA carriers, including environmental disinfection

Group Type OTHER

intervention

Intervention Type OTHER

5 days topical decolonisation including nasal mupirocin tid, chlorhexidine mouth wash tid, chlorhexidine body wash once daily.

Daily direct resident's environmental disinfection during decolonisation.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

intervention

5 days topical decolonisation including nasal mupirocin tid, chlorhexidine mouth wash tid, chlorhexidine body wash once daily.

Daily direct resident's environmental disinfection during decolonisation.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

topical MRSA decolonisation and environmental disinfection

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* all nursing homes of canton Vaud, Switzerland, that give the consent of participation


\- all MRSA positive residents living in a Nursing Home included in the intervention group

Exclusion Criteria

\- refusal to participate


* residents that refuse to be screened or refused the decolonisation
* life expectancy shorter of 7 days
* known intolerance of disinfectant/ topical antibiotics used in the protocol
* active MRSA infection
* asymptomatic MRSA bacteriuria
* stage IV wound (according to National Pressure Ulcer Advisory Panel)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Lausanne Hospitals

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Bellini Cristina

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Giorgio Zanetti, MD

Role: STUDY_DIRECTOR

University Hospital of Lausanne, Switzerland

References

Explore related publications, articles, or registry entries linked to this study.

Bellini C, Petignat C, Masserey E, Bula C, Burnand B, Rousson V, Blanc DS, Zanetti G. Universal screening and decolonization for control of MRSA in nursing homes: a cluster randomized controlled study. Infect Control Hosp Epidemiol. 2015 Apr;36(4):401-8. doi: 10.1017/ice.2014.74.

Reference Type BACKGROUND
PMID: 25782894 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Protocole 96/10

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Bacterial Contamination of Workwear
NCT01192841 COMPLETED NA